A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system
Open Access
- 26 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 295 (26), 8746-8758
- https://doi.org/10.1074/jbc.RA119.012339
Abstract
No abstract availableKeywords
Funding Information
- Lundbeckfonden (BRAINSTRUC, R155-2015-2666)
This publication has 56 references indexed in Scilit:
- Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement SystemFrontiers in Immunology, 2019
- Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic ApplicationsJournal of Innate Immunity, 2018
- Complement activation, regulation, and molecular basis for complement‐related diseasesThe EMBO Journal, 2015
- Complement System Part II: Role in ImmunityFrontiers in Immunology, 2015
- Toward a structure-based comprehension of the lectin pathway of complementMolecular Immunology, 2013
- The Complement System: An Unexpected Role in Synaptic Pruning During Development and DiseaseAnnual Review of Neuroscience, 2012
- New insights into the molecular mechanisms of classical complement activationMolecular Immunology, 2010
- The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplificationMolecular Immunology, 2009
- The tick-over theory revisited: Formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb)Molecular Immunology, 2007
- The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activationClinical and Experimental Immunology, 2004